Overcoming the challenges in drug device combination product formulation

In conversation with Dr. Bruce Frank, V.P – Operations & Client Services, Particle Sciences on overcoming the challenges and complexities in drug device combination product formulation.

GSK and Lyell Immunopharma join forces to develop the next generation of cancer cell therapies

GSK plc announced a five-year collaboration with Lyell Immunopharma, a San Francisco biotechnology company, to develop new technologies to improve cell therapies for cancer patients.

U.S. FDA approves rivaroxaban to help prevent blood clots in acutely ill medical patients

Bayer AG and Janssen Research & Development announced that the U.S. FDA has approved rivaroxaban for the prevention of venous thromboembolism or blood clots, in acutely ill medical patients at risk for...

Thermo Fisher Scientific Completes Acquisition of GSK Manufacturing Site in Cork, Ireland

Thermo Fisher Scientifi has completed its previously announced acquisition of an active pharmaceutical ingredient manufacturing facility from GSK for €90 million. Completion of the transaction follows...

Sanofi Opens Its First Digital Manufacturing Facility in Massachusetts

Sanofi announced it has inaugurated the opening of its first new digital manufacturing facility for biologics production in Framingham, Massachusetts. The digital-enabled aspect of the manufacturing plant...

Insilico Medicine and ChemDiv form a strategic drug discovery service alliance

Insilico Medicine and ChemDiv launched a new strategic collaboration to provide certain pharmal & biotechnology companies with end-to-end drug discovery solutions. This collaboration combines...